Brain imaging: assessing therapy responses using quantitative imaging biomarkers
M. Hwang, M. Oborski, C. Laymon, F. Imani and J. Mountz, University of Pittsburgh, USA
Abstract:
Neuroimaging is essential for both the diagnosis and evaluation of the therapeutic response of intracranial tumors. Measurement of structural changes in tumor morphology after institution of therapy using magnetic resonance imaging (MRI) serves as the current gold standard for monitoring therapeutic response; however, information of prognostic value cannot be obtained until weeks after the initiation of treatment. Positron emission tomography (PET) using radiolabled ligands that trace physiologic processes offers promise as a method for early therapy response assessment, ...
Get Biomedical Imaging now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
